CrisprBits
Bangalore, India· Est.
CRISPR‑based platform delivering affordable diagnostics and gene‑editing solutions for diverse industries.
Is this your company? Claim your profile to update info and connect with investors.
Claim profilePrivate Company
Funding information not available
AI Company Overview
CRISPR‑based platform delivering affordable diagnostics and gene‑editing solutions for diverse industries.
Genetic disordersInfectious diseases
Technology Platform
CRISPR‑Cas based synthetic biology platforms that combine guide‑RNA design, multiplexed detection, and modular gene‑editing workflows for rapid, scalable applications.
Opportunities
Rapid expansion of affordable CRISPR diagnostics and gene‑editing services in emerging markets, and potential regulatory clearance for point‑of‑need infectious disease tests.
Risk Factors
Regulatory approval timelines, IP protection challenges, and competition from established CRISPR diagnostics firms.
Competitive Landscape
Competes with players such as Mammoth Biosciences, Sherlock Biosciences, and Twist Bioscience; differentiates through a diversified platform suite and focus on cost‑effective solutions for low‑resource settings.